A Longitudinal Study of Disability, Cognition and Gray Matter Atrophy in Early Multiple Sclerosis Patients According to Evidence of Disease Activity.
New treatment options may make "no evidence of disease activity" (NEDA: no relapses or disability progression and no new/enlarging MRI lesions, as opposed to "evidence of disease activity" (EDA) with at least one of the former), an achievable goal in relapsing-remitting multiple...
Main Authors: | Gro O Nygaard, Elisabeth G Celius, Sigrid A de Rodez Benavent, Piotr Sowa, Marte W Gustavsen, Anders M Fjell, Nils I Landrø, Kristine B Walhovd, Hanne F Harbo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0135974 |
Similar Items
-
Neurodegenerative Interplay of Cardiovascular Autonomic Dysregulation and the Retina in Early Multiple Sclerosis
by: Sigrid A. de Rodez Benavent, et al.
Published: (2019-05-01) -
Gray Matter Atrophy to Explain Subclinical Oculomotor Deficit in Multiple Sclerosis
by: Bálint Kincses, et al.
Published: (2019-06-01) -
A recipe for accurate estimation of lifespan brain trajectories, distinguishing longitudinal and cohort effects
by: Øystein Sørensen, et al.
Published: (2021-02-01) -
Multiple Sclerosis Risk Allele in CLEC16A Acts as an Expression Quantitative Trait Locus for CLEC16A and SOCS1 in CD4+ T Cells.
by: Ingvild S Leikfoss, et al.
Published: (2015-01-01) -
Identifying miRNAs in multiple sclerosis gray matter lesions that correlate with atrophy measures
by: Ajai Tripathi, et al.
Published: (2021-06-01)